Navigation Links
Warner Chilcott Announces Secondary Equity Offering
Date:11/13/2009

rtainties. The following represent some, but not necessarily all, of the factors that could cause actual results to differ from historical results or those anticipated or predicted by our forward-looking statements: our substantial indebtedness; competitive factors in the industry in which we operate (including the approval and introduction of generic or branded products that compete with our products); our ability to protect our intellectual property; a delay in qualifying our manufacturing facility to produce our products or production or regulatory problems with either third party manufacturers upon whom we may rely for some of our products or our own manufacturing facilities; pricing pressures from reimbursement policies of private managed care organizations and other third party payors, government sponsored health systems, the continued consolidation of the distribution network through which we sell our products, including wholesale drug distributors and the growth of large retail drug store chains; the loss of key senior management or scientific staff; adverse outcomes in our outstanding litigation or an increase in the number of litigation matters to which we are subject; government regulation affecting the development, manufacture, marketing and sale of pharmaceutical products, including our ability and the ability of companies with whom we do business to obtain necessary regulatory approvals; our ability to manage the growth of our business by successfully identifying, developing, acquiring or licensing new products at favorable prices and marketing such new products; our ability to obtain regulatory approval and customer acceptance of new products, and continued customer acceptance of our existing products; changes in tax laws or interpretations that could increase our consolidated tax liabilities; the other risks identified in our periodic filings including our Annual Report on Form 10-K for the year ended December 31, 2008, as amended, and our Current Re
'/>"/>
SOURCE Warner Chilcott plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Warner Chilcott Completes Acquisition of P&Gs Global Branded Prescription Pharmaceuticals Business
2. Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development
3. Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent
4. Tianyin Pharmaceutical co., Inc. Announces Record First Quarter 2010 Financial Results
5. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
6. Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results
7. Misonix Announces New Distribution Agreement for Saudi Arabia and Other Middle Eastern Countries
8. Milestone Scientific Announces Third Quarter 2009 Results
9. EF Johnson Technologies Announces Third Quarter Results
10. Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology
11. LifeVantage Announces Unaudited First Quarter Fiscal 2010 Financial and Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 1, 2015 According to a ... by Product (Natural & Synthetic, Fibrin, Collagen, Gelatin, Cyanoacrylate, ... - Global Forecast to 2020", published by MarketsandMarkets, the ... reach $2.64 Billion by 2020, growing at a CAGR ... Browse 119 market T ables ...
(Date:7/1/2015)... July 1, 2015 Prismic Pharmaceuticals, Inc., a ... medical foods, today announced the election of Joseph ... to its Board of Directors. Commenting on ... Peter Moriarty , Chairman and CEO of Prismic, stated, ... Martin Simonetti have accepted our invitation to ...
(Date:7/1/2015)... , July 1, 2015 Dynatronics ... manufacturer and marketer of rehabilitation and physical therapy ... $4,025,000 private placement financing led by affiliates of ... equity investor focused on the healthcare industry. The ... organic growth and pursue potential strategic acquisitions.  ...
Breaking Medicine Technology:Surgical Sealants and Adhesives Market Worth $2.64 Billion by 2020 2Surgical Sealants and Adhesives Market Worth $2.64 Billion by 2020 3Surgical Sealants and Adhesives Market Worth $2.64 Billion by 2020 4Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3
... , HELSINKI, Dec. 14 Cancer patients in Finland ... of RapidArc® radiotherapy technology from Varian Medical Systems (NYSE: ... the Nordic region. Clinicians at Docrates Clinic in Helsinki are ... patients with multiple brain metastases and cancers of the abdomen ...
... , WALTHAM, Mass., Dec. 14 According to ... market intelligence, increased use of safety devices for small-bore connectors ... of the enteral feeding device markets in both the US ... Enteral Feeding Devices 2010 report finds that the giving ...
Cached Medicine Technology:Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3
(Date:7/1/2015)... ... July 01, 2015 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... that they will welcome four new members to their industry leading Scientific Advisory ...
(Date:7/1/2015)... Chesapeake, VA (PRWEB) , ... July 01, 2015 , ... ... interviewed on Monday, July 6th on WAVY-TV’s The Hampton Roads Show to discuss non-invasive ... results where diet and exercise fall short. , CoolSculpting fat reduction utilizes Cryolipolysis ...
(Date:7/1/2015)... ... 01, 2015 , ... During the first week of June, ... and Development) and Chuck Corso (Associate Sales Trainer) participated in the 44th Annual ... together learning and development professionals from more than 300 life sciences companies around ...
(Date:7/1/2015)... ... July 01, 2015 , ... Convoy of Hope ... in the Twin Cities on Saturday, August 1, at Spring Lake Park High School. ... provide more than $1 million worth of goods and services including free food, health ...
(Date:7/1/2015)... ... 01, 2015 , ... Element Blue ™, a leading ... it has received trademark protection for its SensorInsight® computer software platform. SensorInsight® is ... multiple sources providing an environment where users can view and compare real-time and ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Convoy of Hope Hosts Community Event in the Twin Cities 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4
... direct marketing promotional products company, offers a specialty store filled ... ... Lewiston, ME (PRWEB) February 19, 2009 -- Crestline ... that trades on its easy, customer-friendly ordering process, offers ...
... Natrecor for a Use Not Approved By the Food ... has intervened in two whistleblower suits filed in the ... Inc. and its parent company, Johnson & Johnson Inc., ... for a use not approved by the Food and ...
... Indicates a 40% Reduction of Intraocular Pressure at Two ... today that it has surpassed 1000 implantation procedures with ... reduces intraocular pressure (IOP) for the treatment of glaucoma. ... President and Founder of SOLX, "as it validates the ...
... to Consumer-Directed Health Plans Continues, Watson Wyatt/National Business Group ... expect health care cost increases to hold steady at ... plans (CDHPs) in 2010 in an effort to control ... Wyatt, a leading global consulting firm, and the National ...
... to risk-taking, too, study finds, , , THURSDAY, Feb. ... makes people love skydiving, mountain-climbing or other intense ... the brain that has been linked to addictive ... researchers studied volunteers who were grouped as either ...
... percent less likely than men to receive a critical ... stroke, according to a Michigan State University study. , ... Diego at the International Stroke Conference, organized by the ... plasminogen activator, or tPA, first approved as a treatment ...
Cached Medicine News:Health News:Crestline is the Source for Great Green Giveaways 2Health News:Crestline is the Source for Great Green Giveaways 3Health News:United States Joins Suits Against Scios and Johnson & Johnson 2Health News:United States Joins Suits Against Scios and Johnson & Johnson 3Health News:SOLX Announces 1000th Gold Shunt Implantation Milestone for Glaucoma Treatment 2Health News:Health Care Benefit Cost Increases to Remain at 6 Percent in 2009 2Health News:Health Care Benefit Cost Increases to Remain at 6 Percent in 2009 3Health News:Thrill-Seekers' Brains May Be Wired Differently 2Health News:Women less likely to receive critical care after a stroke, MSU researchers find 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: